Disease Specific Interactions between Host Protein and DME (HOSPPI) |
ICD Disease Classification Healthy |
ICD-11: Healthy |
Click to Show/Hide the Full List of HOSPPI: 7 HOSPPI
|
Oligomerization |
Cytochrome P450 1A1 (CYP1A1) |
Health |
Heterooligomer |
Uniprot ID |
|
Interaction Name |
CYP1A1-UGT1A1 heterooligomerization |
[1] |
Studied Cell Lines |
liver microsomes |
Description |
Cytochrome P450 1A1 (CYP1A1) is reported to heterooligomerize with the UGT1A1 protein, which leads to an increased activity of the drug-metabolizing enzyme UDP-glucuronosyltransferase 1A1. As a result, the interaction between CYP1A1 and UGT1A1 can facilitate the drug-metabolizing process of UDP-glucuronosyltransferase 1A1. |
Mutated UDPGT 1-1 (mUGT1A1) |
Health |
Homodimer |
Uniprot ID |
|
Interaction Name |
mUGT1A1-UGT1A1 homodimerization |
[4] |
Studied Cell Lines |
Monkey kidney fibroblast-like cell line (COS)7 |
Description |
Mutated UDPGT 1-1 (mUGT1A1) is reported to homodimerize with the UGT1A1 protein, which leads to a markedly suppressed activity of the drug-metabolizing enzyme UDP-glucuronosyltransferase 1A1. As a result, the interaction between mUGT1A1 and UGT1A1 can markedly inhibit the drug-metabolizing process of UDP-glucuronosyltransferase 1A1. |
UDPGT 1-1 (UGT1A1) |
Health |
Homodimer |
Uniprot ID |
|
Interaction Name |
UGT1A1-UGT1A1 homodimerization |
[5] |
Studied Cell Lines |
Monkey kidney fibroblast-like cell line (COS) |
Affected Substrate(s): |
Octylgallate
|
Description |
UDPGT 1-1 (UGT1A1) is reported as a homodimer, which leads to a slight effect on the enzyme activity of drug-metabolizing enzyme UDP-glucuronosyltransferase 1A1. As a result, the UGT1A1 homodimerization can slightly affect the drug-metabolizing process of UDP-glucuronosyltransferase 1A1. |
UDPGT 1-9 (UGT1A9) |
Health |
Heterooligomer |
Uniprot ID |
|
Interaction Name |
UGT1A9-UGT1A1 heterooligomerization |
[6] |
Studied Cell Lines |
Human embryonic kidney cell line (HEK293) |
Affected Substrate(s): |
Estradiol (Metabolic product: Estradiol 3-O-glucuronide)
|
Activity |
Decreasing Vmax |
Description |
UDPGT 1-9 (UGT1A9) is reported to heterooligomerize with the UGT1A1 protein, which leads to a suppressed activity of the drug-metabolizing enzyme UDP-glucuronosyltransferase 1A1. As a result, the interaction between UGT1A9 and UGT1A1 can inhibit the drug-metabolizing process of UDP-glucuronosyltransferase 1A1. |
Histone modification |
Histone deacetylases (HDACs) |
Health |
Repression |
Uniprot ID |
|
Interaction Name |
HDACs-UGT1A1 interaction |
[2] |
Studied Cell Lines |
Human kidney-derived HK-2 cells |
Description |
Histone deacetylases (HDACs) are reported to deacetylate the UGT1A1 gene and thereby repress the transcriptional activity of the drug-metabolizing enzyme UDP-glucuronosyltransferase 1A1. As a result, the interaction between HDACs and UGT1A1 can inhibit the drug-metabolizing process of UDP-glucuronosyltransferase 1A1. |
Histone methyltransferases (HMTs) |
Health |
Repression |
Uniprot ID |
|
Interaction Name |
HMTs-UGT1A1 interaction |
[3] |
Studied Cell Lines |
Fetal liver cells |
Description |
The Histone 3 lysine 27 trimethylation of UGT1A1 gene is reported to repress the transcriptional activity of the drug-metabolizing enzyme UDP-glucuronosyltransferase 1A1. As a result, the interaction between Histone methyltransferases (HMTs) and UGT1A1 can inhibit the drug-metabolizing process of UDP-glucuronosyltransferase 1A1. |
Histone methyltransferases (HMTs) |
Health |
Activation |
Uniprot ID |
|
Interaction Name |
HMTs-UGT1A1 interaction |
[3] |
Studied Cell Lines |
Adult liver cells |
Description |
The Histone 3 lysine 4 dimethylation of UGT1A1 gene is reported to activate the transcriptional activity of the drug-metabolizing enzyme UDP-glucuronosyltransferase 1A1. As a result, the interaction between Histone methyltransferases (HMTs) and UGT1A1 can enhance the drug-metabolizing process of UDP-glucuronosyltransferase 1A1. |
ICD Disease Classification 02 Neoplasms |
ICD-11: 2B90 Colorectal cancer |
Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI
|
DNA methylation |
DNA methyltransferase (DNMT) |
Colorectal cancer |
Significant hypermethylation |
Uniprot ID |
|
Interaction Name |
DNMT-UGT1A1 interaction |
[7] |
Studied Cell Lines |
Colon tissue |
Description |
DNA methyltransferase (DNMT) is reported to significantly hyper-methylate the UGT1A1 gene, which leads to a significantly decreased expression of the drug-metabolizing enzyme UDP-glucuronosyltransferase 1A1. As a result, the interaction between DNMT and UGT1A1 can significantly affect the drug-metabolizing process of UDP-glucuronosyltransferase 1A1. |
ICD-11: 2C12 Liver cancer |
Click to Show/Hide the Full List of HOSPPI: 5 HOSPPI
|
Transcription-factor regulation |
Aryl hydrocarbon receptor (AHR) |
Liver cancer |
Activation |
Uniprot ID |
|
Interaction Name |
AHR-UGT1A1 interaction |
[8] |
Studied Cell Lines |
HepG2 cell line |
Ensembl ID |
|
Description |
Aryl hydrocarbon receptor (AHR) is reported to activate the transcription of UGT1A1 gene, which leads to an increased expression of the drug-metabolizing enzyme UDP-glucuronosyltransferase 1A1. As a result, the interaction between AHR and UGT1A1 can activate the drug-metabolizing process of UDP-glucuronosyltransferase 1A1. |
Glucocorticoid receptor (NR3C1) |
Liver cancer |
Activation |
Uniprot ID |
|
Interaction Name |
NR3C1-UGT1A1 interaction |
[8] |
Studied Cell Lines |
HepG2 cell line |
Ensembl ID |
|
Description |
Glucocorticoid receptor (NR3C1) is reported to activate the transcription of UGT1A1 gene, which leads to an increased expression of the drug-metabolizing enzyme UDP-glucuronosyltransferase 1A1. As a result, the interaction between NR3C1 and UGT1A1 can activate the drug-metabolizing process of UDP-glucuronosyltransferase 1A1. |
Hepatocyte NF 1-alpha (HNF1A) |
Liver cancer |
Activation |
Uniprot ID |
|
Interaction Name |
HNF1A-UGT1A1 interaction |
[8] |
Studied Cell Lines |
HepG2 cell line |
Ensembl ID |
|
Description |
Hepatocyte NF 1-alpha (HNF1A) is reported to activate the transcription of UGT1A1 gene, which leads to an increased expression of the drug-metabolizing enzyme UDP-glucuronosyltransferase 1A1. As a result, the interaction between HNF1A and UGT1A1 can activate the drug-metabolizing process of UDP-glucuronosyltransferase 1A1. |
Nuclear receptor family 0 I3 (NR1I3) |
Liver cancer |
Activation |
Uniprot ID |
|
Interaction Name |
NR1I3-UGT1A1 interaction |
[8] |
Studied Cell Lines |
HepG2 cell line |
Ensembl ID |
|
Description |
Nuclear receptor family 0 I3 (NR1I3) is reported to activate the transcription of UGT1A1 gene, which leads to an increased expression of the drug-metabolizing enzyme UDP-glucuronosyltransferase 1A1. As a result, the interaction between NR1I3 and UGT1A1 can activate the drug-metabolizing process of UDP-glucuronosyltransferase 1A1. |
Pregnane X receptor (PXR) |
Liver cancer |
Activation |
Uniprot ID |
|
Interaction Name |
PXR-UGT1A1 interaction |
[8] |
Studied Cell Lines |
HepG2 cell line |
Ensembl ID |
|
Description |
Pregnane X receptor (PXR) is reported to activate the transcription of UGT1A1 gene, which leads to an increased expression of the drug-metabolizing enzyme UDP-glucuronosyltransferase 1A1. As a result, the interaction between PXR and UGT1A1 can activate the drug-metabolizing process of UDP-glucuronosyltransferase 1A1. |
|
|
|
|
|
|